PL3661508T3 - Sposób wytwarzania doustnej postaci dawkowania zawierającej berberynę, doustna postać dawkowania zawierająca berberynę i jej zastosowanie - Google Patents
Sposób wytwarzania doustnej postaci dawkowania zawierającej berberynę, doustna postać dawkowania zawierająca berberynę i jej zastosowanieInfo
- Publication number
- PL3661508T3 PL3661508T3 PL17764504.1T PL17764504T PL3661508T3 PL 3661508 T3 PL3661508 T3 PL 3661508T3 PL 17764504 T PL17764504 T PL 17764504T PL 3661508 T3 PL3661508 T3 PL 3661508T3
- Authority
- PL
- Poland
- Prior art keywords
- dosage form
- oral dosage
- form containing
- containing berberine
- manufacturing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CZ2017/050033 WO2019024949A1 (en) | 2017-08-02 | 2017-08-02 | METHOD FOR MANUFACTURING ORAL DOSAGE FORM CONTAINING BERBERIN, ORAL DOSAGE FORM CONTAINING BERBERIN AND USE THEREOF |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3661508T3 true PL3661508T3 (pl) | 2024-10-07 |
Family
ID=59829106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17764504.1T PL3661508T3 (pl) | 2017-08-02 | 2017-08-02 | Sposób wytwarzania doustnej postaci dawkowania zawierającej berberynę, doustna postać dawkowania zawierająca berberynę i jej zastosowanie |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP3661508B1 (pl) |
| PL (1) | PL3661508T3 (pl) |
| WO (1) | WO2019024949A1 (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109875971A (zh) * | 2019-03-19 | 2019-06-14 | 中山大学 | 一种盐酸小檗碱缓释片及其制备方法 |
| CN111686084B (zh) * | 2020-06-24 | 2021-04-09 | 宜春万申制药机械有限公司 | 一种盐酸小檗碱谷维素片剂在治疗糖尿病中的应用 |
| CN111603468B (zh) * | 2020-06-30 | 2021-04-30 | 王天怡 | 一种小檗碱组合物及其制备方法和应用 |
| EP4251136A1 (en) * | 2020-11-24 | 2023-10-04 | Specchiasol S.r.l. | Formulation for oral administration of active compounds with low bioavailability and corresponding production method |
| CN116270516A (zh) * | 2023-03-17 | 2023-06-23 | 江苏亚邦爱普森药业有限公司 | 一种盐酸小檗碱包衣片剂及其制备方法 |
| CN120605251B (zh) * | 2025-08-07 | 2025-10-24 | 重庆士立德医药科技有限公司 | 乙酰半胱氨酸口崩片及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0227108B1 (en) | 1985-12-27 | 1993-03-31 | Lion Corporation | Oral composition |
| CN105030689A (zh) * | 2006-09-19 | 2015-11-11 | 太阳石（唐山）药业有限公司 | 盐酸小檗碱掩味微丸及其制剂 |
| US9358261B2 (en) * | 2011-10-25 | 2016-06-07 | U.S. Phytotherapy, Inc. | Additional artemisinin and berberine compositions and methods of making |
| WO2013063271A1 (en) | 2011-10-25 | 2013-05-02 | U.S. Phytotherapy, Inc. | Artemisinin and berberine compositions and methods of making |
| JP5873394B2 (ja) * | 2012-06-14 | 2016-03-01 | ライオン株式会社 | タンニン酸ベルベリン粒子及びその製造方法、錠剤 |
| WO2015097642A1 (en) * | 2013-12-26 | 2015-07-02 | Rao Raavi Chandra Sekhar | Composition for treating cancer and method of synthesizing the same |
| EP2937077B1 (en) | 2014-04-24 | 2021-10-06 | Montero Gida Sanayi Ve Ticaret A.S. | Oral liquid formulations comprising herbal extracts |
| ITUB20150541A1 (it) * | 2015-03-03 | 2016-09-03 | Acraf | Composizione comprendente sostanze e/o estratti naturali |
-
2017
- 2017-08-02 WO PCT/CZ2017/050033 patent/WO2019024949A1/en not_active Ceased
- 2017-08-02 PL PL17764504.1T patent/PL3661508T3/pl unknown
- 2017-08-02 EP EP17764504.1A patent/EP3661508B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3661508B1 (en) | 2024-05-22 |
| WO2019024949A1 (en) | 2019-02-07 |
| EP3661508A1 (en) | 2020-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273706A (en) | Liquid dosage forms, methods of preparation and uses | |
| DK3720496T3 (en) | Solid oral nicotine formulation | |
| PT3449945T (pt) | Substância que contém aglomerado de ouro e método de preparação e utilização da mesma | |
| SMT202200122T1 (it) | Derivato di benzazepina, metodo di preparazione, composizione farmaceutica e suo uso | |
| IL258143A (en) | Nicotine composition for inhalation and methods for their preparation and use | |
| PT3487505T (pt) | Administração e dosagem de diaminofenotiazinas | |
| ZA201708429B (en) | Oral solid formulation containing irinotecan and method of preparing the same | |
| IL272446A (en) | Penta-condensed hexa-heterocyclic compounds, method for their preparation, drug combination and use thereof | |
| SG11202106282RA (en) | Biochip, method of preparation and use thereof | |
| SG11202101905YA (en) | Vitamin d pediatric dosage forms, methods of making and using | |
| PT3421038T (pt) | Compostos de naftiridina, combinações médicas e sua utilização | |
| PL3373910T3 (pl) | Preparat echinomycyny, sposób wytwarzania i sposób stosowania | |
| IL256350A (en) | Compositions and methods for the treatment of substance use disorders, addiction, and psychiatric disorders | |
| GB201601865D0 (en) | Oral dosage products and processes | |
| IL268458A (en) | Nicotine inhalable formulations and methods of making and using them | |
| ZA201807476B (en) | Oral care composition and method of use | |
| IL276430A (en) | A pharmaceutical compound, its cures, its formulations, and methods for its preparation and use | |
| IL266938A (en) | Pharmaceutical preparation and method for its production | |
| ZA202000609B (en) | Novel composition of enzalutamide oral dosage form and method of manufacturing thereof | |
| GB201708500D0 (en) | Oral care composition, process for preparation and method of use thereof | |
| IL254597A0 (en) | Crystalline form of ahu377, method for its preparation and use | |
| PT3277266T (pt) | Forma de dosagem oral sólida de amlodipina e usos veterinários da mesma | |
| IL271727A (en) | Method of treatment and their dosage forms | |
| PL3270912T4 (pl) | Kompozycje farmaceutyczne zawierające kompleksy taksan-cyklodekstryna, sposób wytwarzania i sposoby zastosowania | |
| HUE064344T2 (hu) | Gyógyászati vegyület, elõállítása és gyógyszerként történõ alkalmazása |